Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors
This study has been completed.
Study NCT00030095 Information provided by National Cancer Institute (NCI)
First Received on January 30, 2002. Last Updated on December 5, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Neoplasms
Interventions listed in this trial
2-methoxyestradiol
Additional drug interventions recognized in this trial
Angiogenesis Inhibitors
Estradiol
More general drug interventions related to this trial
Angiogenesis Modulating Agents
Antimitotic Agents
Antineoplastic Agents
Estrogens
Growth Inhibitors
Growth Substances
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
National Cancer Institute (NCI)
Back to top of Main Content